Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

C-RAD Report Publication Announcement 2017

Aug 14, 2017

3148_rns_2017-08-14_7f8d66fb-41ec-4128-84ee-2bc5efc00104.pdf

Report Publication Announcement

Open in viewer

Opens in your device viewer

Press release 2017-8-14

Reminder: C-RAD Web Presentation Half Year Report 2017

Presentation of the report for the first half of the fiscal year 2017:

Date: Wednesday August 16, 2017 / kl. 11:00

Venue: Online Presentation

Topic: C-RAD Half Year Report 2017

Procedure:

Please register online through the website:

https://attendee.gotowebinar.com/register/2622476354293209347

After your registration, you will receive a confirmation via email.

A recording of the presentation will be made accessible on the C-RAD website after the presentation.

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. For more information on C-RAD, please visit www.c-rad.com

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email [email protected]